nodes	percent_of_prediction	percent_of_DWPC	metapath
Pasireotide—SSTR1—SIDS Susceptibility Pathways—LMX1B—glaucoma	0.0146	0.0415	CbGpPWpGaD
Pasireotide—SSTR2—SIDS Susceptibility Pathways—LMX1B—glaucoma	0.012	0.0339	CbGpPWpGaD
Pasireotide—SSTR2—GPCRs, Other—PTGFR—glaucoma	0.0103	0.029	CbGpPWpGaD
Pasireotide—SSTR3—GPCRs, Class A Rhodopsin-like—MAS1—glaucoma	0.00689	0.0195	CbGpPWpGaD
Pasireotide—SSTR1—GPCRs, Class A Rhodopsin-like—MAS1—glaucoma	0.00661	0.0187	CbGpPWpGaD
Pasireotide—SSTR3—GPCRs, Class A Rhodopsin-like—OPN4—glaucoma	0.0063	0.0179	CbGpPWpGaD
Pasireotide—SSTR1—GPCRs, Class A Rhodopsin-like—OPN4—glaucoma	0.00604	0.0171	CbGpPWpGaD
Pasireotide—SSTR5—GPCRs, Class A Rhodopsin-like—MAS1—glaucoma	0.00586	0.0166	CbGpPWpGaD
Pasireotide—SSTR3—GPCRs, Class A Rhodopsin-like—PTGFR—glaucoma	0.00568	0.0161	CbGpPWpGaD
Pasireotide—SSTR1—GPCRs, Class A Rhodopsin-like—PTGFR—glaucoma	0.00544	0.0154	CbGpPWpGaD
Pasireotide—SSTR2—GPCRs, Class A Rhodopsin-like—MAS1—glaucoma	0.00541	0.0153	CbGpPWpGaD
Pasireotide—SSTR3—Class A/1 (Rhodopsin-like receptors)—OPN4—glaucoma	0.0054	0.0153	CbGpPWpGaD
Pasireotide—SSTR5—GPCRs, Class A Rhodopsin-like—OPN4—glaucoma	0.00536	0.0152	CbGpPWpGaD
Pasireotide—SSTR1—SIDS Susceptibility Pathways—HDAC9—glaucoma	0.00524	0.0149	CbGpPWpGaD
Pasireotide—SSTR1—Class A/1 (Rhodopsin-like receptors)—OPN4—glaucoma	0.00518	0.0147	CbGpPWpGaD
Pasireotide—SSTR2—GPCRs, Other—SMO—glaucoma	0.00517	0.0146	CbGpPWpGaD
Pasireotide—SSTR2—GPCRs, Class A Rhodopsin-like—OPN4—glaucoma	0.00495	0.014	CbGpPWpGaD
Pasireotide—SSTR3—Class A/1 (Rhodopsin-like receptors)—PTGFR—glaucoma	0.00486	0.0138	CbGpPWpGaD
Pasireotide—SSTR5—GPCRs, Class A Rhodopsin-like—PTGFR—glaucoma	0.00483	0.0137	CbGpPWpGaD
Pasireotide—SSTR1—Class A/1 (Rhodopsin-like receptors)—PTGFR—glaucoma	0.00466	0.0132	CbGpPWpGaD
Pasireotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—OPN4—glaucoma	0.00459	0.013	CbGpPWpGaD
Pasireotide—SSTR2—GPCRs, Class A Rhodopsin-like—PTGFR—glaucoma	0.00445	0.0126	CbGpPWpGaD
Pasireotide—SSTR2—SIDS Susceptibility Pathways—HDAC9—glaucoma	0.00429	0.0122	CbGpPWpGaD
Pasireotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—OPN4—glaucoma	0.00424	0.012	CbGpPWpGaD
Pasireotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—PTGFR—glaucoma	0.00413	0.0117	CbGpPWpGaD
Pasireotide—SSTR3—GPCR ligand binding—OPN4—glaucoma	0.00411	0.0117	CbGpPWpGaD
Pasireotide—SSTR1—GPCR ligand binding—OPN4—glaucoma	0.00394	0.0112	CbGpPWpGaD
Pasireotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—PTGFR—glaucoma	0.00382	0.0108	CbGpPWpGaD
Pasireotide—SSTR1—SIDS Susceptibility Pathways—NTRK2—glaucoma	0.00375	0.0106	CbGpPWpGaD
Pasireotide—SSTR3—GPCR ligand binding—PTGFR—glaucoma	0.0037	0.0105	CbGpPWpGaD
Pasireotide—SSTR1—GPCR ligand binding—PTGFR—glaucoma	0.00355	0.0101	CbGpPWpGaD
Pasireotide—Dry skin—Pilocarpine—glaucoma	0.00354	0.00547	CcSEcCtD
Pasireotide—Influenza—Dorzolamide—glaucoma	0.00353	0.00546	CcSEcCtD
Pasireotide—Influenza—Travoprost—glaucoma	0.00351	0.00543	CcSEcCtD
Pasireotide—SSTR5—GPCR ligand binding—OPN4—glaucoma	0.0035	0.00991	CbGpPWpGaD
Pasireotide—Vertigo—Methazolamide—glaucoma	0.00348	0.00538	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Metipranolol—glaucoma	0.00344	0.00531	CcSEcCtD
Pasireotide—Oedema peripheral—Apraclonidine—glaucoma	0.00339	0.00525	CcSEcCtD
Pasireotide—Influenza—Pilocarpine—glaucoma	0.00334	0.00515	CcSEcCtD
Pasireotide—Oedema peripheral—Bimatoprost—glaucoma	0.00329	0.00509	CcSEcCtD
Pasireotide—Hypotension—Carteolol—glaucoma	0.00327	0.00505	CcSEcCtD
Pasireotide—SSTR2—GPCR ligand binding—OPN4—glaucoma	0.00323	0.00914	CbGpPWpGaD
Pasireotide—Arthralgia—Latanoprost—glaucoma	0.00319	0.00494	CcSEcCtD
Pasireotide—Hyperglycaemia—Dorzolamide—glaucoma	0.00318	0.00492	CcSEcCtD
Pasireotide—Insomnia—Carteolol—glaucoma	0.00316	0.00489	CcSEcCtD
Pasireotide—SSTR5—GPCR ligand binding—PTGFR—glaucoma	0.00315	0.00892	CbGpPWpGaD
Pasireotide—Hypotension—Carbachol—glaucoma	0.00313	0.00484	CcSEcCtD
Pasireotide—Hypotension—Levobunolol—glaucoma	0.00309	0.00477	CcSEcCtD
Pasireotide—Diabetes mellitus—Betaxolol—glaucoma	0.00308	0.00477	CcSEcCtD
Pasireotide—Pain in extremity—Clonidine—glaucoma	0.00308	0.00476	CcSEcCtD
Pasireotide—SSTR2—SIDS Susceptibility Pathways—NTRK2—glaucoma	0.00307	0.0087	CbGpPWpGaD
Pasireotide—Decreased appetite—Diclofenamide—glaucoma	0.00299	0.00462	CcSEcCtD
Pasireotide—Fatigue—Diclofenamide—glaucoma	0.00296	0.00458	CcSEcCtD
Pasireotide—Constipation—Diclofenamide—glaucoma	0.00294	0.00454	CcSEcCtD
Pasireotide—SSTR2—GPCR ligand binding—PTGFR—glaucoma	0.00291	0.00823	CbGpPWpGaD
Pasireotide—Abdominal pain upper—Clonidine—glaucoma	0.00281	0.00435	CcSEcCtD
Pasireotide—SSTR1—SIDS Susceptibility Pathways—BDNF—glaucoma	0.0028	0.00794	CbGpPWpGaD
Pasireotide—Musculoskeletal discomfort—Latanoprost—glaucoma	0.00279	0.00431	CcSEcCtD
Pasireotide—Nasopharyngitis—Clonidine—glaucoma	0.00276	0.00426	CcSEcCtD
Pasireotide—Decreased appetite—Methazolamide—glaucoma	0.00275	0.00425	CcSEcCtD
Pasireotide—Hypoglycaemia—Betaxolol—glaucoma	0.00275	0.00425	CcSEcCtD
Pasireotide—Oedema peripheral—Brinzolamide—glaucoma	0.00274	0.00423	CcSEcCtD
Pasireotide—Fatigue—Methazolamide—glaucoma	0.00273	0.00422	CcSEcCtD
Pasireotide—Asthenia—Metipranolol—glaucoma	0.00271	0.00418	CcSEcCtD
Pasireotide—SSTR1—SIDS Susceptibility Pathways—IL1A—glaucoma	0.00269	0.00762	CbGpPWpGaD
Pasireotide—Abdominal pain—Carbachol—glaucoma	0.00265	0.0041	CcSEcCtD
Pasireotide—Oedema peripheral—Pilocarpine—glaucoma	0.00263	0.00406	CcSEcCtD
Pasireotide—Vertigo—Bimatoprost—glaucoma	0.00261	0.00404	CcSEcCtD
Pasireotide—Myalgia—Apraclonidine—glaucoma	0.00255	0.00395	CcSEcCtD
Pasireotide—Hypertension—Bimatoprost—glaucoma	0.00251	0.00388	CcSEcCtD
Pasireotide—Asthenia—Carteolol—glaucoma	0.00251	0.00388	CcSEcCtD
Pasireotide—Alopecia—Dorzolamide—glaucoma	0.0025	0.00386	CcSEcCtD
Pasireotide—Dizziness—Metipranolol—glaucoma	0.00249	0.00386	CcSEcCtD
Pasireotide—SSTR1—SIDS Susceptibility Pathways—NGF—glaucoma	0.00249	0.00704	CbGpPWpGaD
Pasireotide—SSTR1—SIDS Susceptibility Pathways—NR3C1—glaucoma	0.00247	0.00701	CbGpPWpGaD
Pasireotide—Anxiety—Bimatoprost—glaucoma	0.00247	0.00381	CcSEcCtD
Pasireotide—Asthenia—Diclofenamide—glaucoma	0.00247	0.00381	CcSEcCtD
Pasireotide—Alopecia—Brinzolamide—glaucoma	0.00245	0.00379	CcSEcCtD
Pasireotide—Hypokalaemia—Betaxolol—glaucoma	0.00244	0.00377	CcSEcCtD
Pasireotide—Pruritus—Diclofenamide—glaucoma	0.00243	0.00376	CcSEcCtD
Pasireotide—Aspartate aminotransferase increased—Betaxolol—glaucoma	0.00242	0.00373	CcSEcCtD
Pasireotide—SSTR3—Peptide ligand-binding receptors—EDN1—glaucoma	0.00241	0.00683	CbGpPWpGaD
Pasireotide—Nasopharyngitis—Betaxolol—glaucoma	0.0024	0.00371	CcSEcCtD
Pasireotide—Back pain—Dorzolamide—glaucoma	0.00238	0.00368	CcSEcCtD
Pasireotide—Asthenia—Levobunolol—glaucoma	0.00237	0.00366	CcSEcCtD
Pasireotide—Back pain—Travoprost—glaucoma	0.00237	0.00366	CcSEcCtD
Pasireotide—Alanine aminotransferase increased—Betaxolol—glaucoma	0.00237	0.00366	CcSEcCtD
Pasireotide—Headache—Metipranolol—glaucoma	0.00236	0.00365	CcSEcCtD
Pasireotide—Alopecia—Pilocarpine—glaucoma	0.00236	0.00365	CcSEcCtD
Pasireotide—Back pain—Brinzolamide—glaucoma	0.00234	0.00361	CcSEcCtD
Pasireotide—Pruritus—Levobunolol—glaucoma	0.00234	0.00361	CcSEcCtD
Pasireotide—SSTR3—GPCR downstream signaling—OPN4—glaucoma	0.00232	0.00659	CbGpPWpGaD
Pasireotide—Influenza—Betaxolol—glaucoma	0.00232	0.00358	CcSEcCtD
Pasireotide—Dizziness—Carteolol—glaucoma	0.00231	0.00357	CcSEcCtD
Pasireotide—SSTR1—Peptide ligand-binding receptors—EDN1—glaucoma	0.00231	0.00655	CbGpPWpGaD
Pasireotide—Diarrhoea—Carbachol—glaucoma	0.00229	0.00355	CcSEcCtD
Pasireotide—SSTR2—SIDS Susceptibility Pathways—BDNF—glaucoma	0.00229	0.0065	CbGpPWpGaD
Pasireotide—Dizziness—Diclofenamide—glaucoma	0.00227	0.00351	CcSEcCtD
Pasireotide—Asthenia—Methazolamide—glaucoma	0.00227	0.00351	CcSEcCtD
Pasireotide—Diarrhoea—Levobunolol—glaucoma	0.00226	0.00349	CcSEcCtD
Pasireotide—Back pain—Pilocarpine—glaucoma	0.00225	0.00347	CcSEcCtD
Pasireotide—Hypoglycaemia—Timolol—glaucoma	0.00225	0.00347	CcSEcCtD
Pasireotide—Nausea—Metipranolol—glaucoma	0.00224	0.00346	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Apraclonidine—glaucoma	0.00223	0.00345	CcSEcCtD
Pasireotide—SSTR1—GPCR downstream signaling—OPN4—glaucoma	0.00223	0.00631	CbGpPWpGaD
Pasireotide—Hypertension—Brimonidine—glaucoma	0.00222	0.00344	CcSEcCtD
Pasireotide—Dizziness—Carbachol—glaucoma	0.00222	0.00343	CcSEcCtD
Pasireotide—Insomnia—Apraclonidine—glaucoma	0.00221	0.00342	CcSEcCtD
Pasireotide—Vertigo—Dorzolamide—glaucoma	0.00221	0.00342	CcSEcCtD
Pasireotide—SSTR2—SIDS Susceptibility Pathways—IL1A—glaucoma	0.0022	0.00624	CbGpPWpGaD
Pasireotide—Vertigo—Travoprost—glaucoma	0.0022	0.0034	CcSEcCtD
Pasireotide—Arthralgia—Brimonidine—glaucoma	0.00219	0.00339	CcSEcCtD
Pasireotide—Myalgia—Brimonidine—glaucoma	0.00219	0.00339	CcSEcCtD
Pasireotide—Pain in extremity—Timolol—glaucoma	0.00219	0.00339	CcSEcCtD
Pasireotide—Headache—Carteolol—glaucoma	0.00219	0.00338	CcSEcCtD
Pasireotide—Anxiety—Brimonidine—glaucoma	0.00219	0.00338	CcSEcCtD
Pasireotide—Vomiting—Diclofenamide—glaucoma	0.00218	0.00338	CcSEcCtD
Pasireotide—Dizziness—Levobunolol—glaucoma	0.00218	0.00338	CcSEcCtD
Pasireotide—Vertigo—Brinzolamide—glaucoma	0.00217	0.00336	CcSEcCtD
Pasireotide—Pruritus—Latanoprost—glaucoma	0.00217	0.00335	CcSEcCtD
Pasireotide—Diarrhoea—Methazolamide—glaucoma	0.00216	0.00335	CcSEcCtD
Pasireotide—Headache—Diclofenamide—glaucoma	0.00215	0.00333	CcSEcCtD
Pasireotide—Insomnia—Bimatoprost—glaucoma	0.00215	0.00332	CcSEcCtD
Pasireotide—Vomiting—Carbachol—glaucoma	0.00213	0.0033	CcSEcCtD
Pasireotide—Hypertension—Dorzolamide—glaucoma	0.00212	0.00328	CcSEcCtD
Pasireotide—Hypertension—Travoprost—glaucoma	0.00211	0.00327	CcSEcCtD
Pasireotide—Fatigue—Apraclonidine—glaucoma	0.00211	0.00326	CcSEcCtD
Pasireotide—SSTR3—Signaling by GPCR—OPN4—glaucoma	0.00211	0.00598	CbGpPWpGaD
Pasireotide—SSTR3—Peptide ligand-binding receptors—C3—glaucoma	0.00211	0.00597	CbGpPWpGaD
Pasireotide—Headache—Carbachol—glaucoma	0.0021	0.00325	CcSEcCtD
Pasireotide—Arthralgia—Dorzolamide—glaucoma	0.00209	0.00324	CcSEcCtD
Pasireotide—Constipation—Apraclonidine—glaucoma	0.00209	0.00324	CcSEcCtD
Pasireotide—SSTR3—GPCR downstream signaling—PTGFR—glaucoma	0.00209	0.00593	CbGpPWpGaD
Pasireotide—Hyperglycaemia—Betaxolol—glaucoma	0.00209	0.00323	CcSEcCtD
Pasireotide—Hypertension—Brinzolamide—glaucoma	0.00209	0.00323	CcSEcCtD
Pasireotide—Anxiety—Dorzolamide—glaucoma	0.00209	0.00322	CcSEcCtD
Pasireotide—Myalgia—Travoprost—glaucoma	0.00209	0.00322	CcSEcCtD
Pasireotide—Arthralgia—Travoprost—glaucoma	0.00209	0.00322	CcSEcCtD
Pasireotide—Anxiety—Travoprost—glaucoma	0.00208	0.00321	CcSEcCtD
Pasireotide—Nausea—Carteolol—glaucoma	0.00208	0.00321	CcSEcCtD
Pasireotide—Headache—Levobunolol—glaucoma	0.00207	0.0032	CcSEcCtD
Pasireotide—Myalgia—Brinzolamide—glaucoma	0.00206	0.00318	CcSEcCtD
Pasireotide—Arthralgia—Brinzolamide—glaucoma	0.00206	0.00318	CcSEcCtD
Pasireotide—SSTR5—Peptide ligand-binding receptors—EDN1—glaucoma	0.00205	0.00581	CbGpPWpGaD
Pasireotide—Nausea—Diclofenamide—glaucoma	0.00204	0.00315	CcSEcCtD
Pasireotide—SSTR2—SIDS Susceptibility Pathways—NGF—glaucoma	0.00203	0.00577	CbGpPWpGaD
Pasireotide—Dizziness—Latanoprost—glaucoma	0.00203	0.00313	CcSEcCtD
Pasireotide—SSTR2—SIDS Susceptibility Pathways—NR3C1—glaucoma	0.00203	0.00574	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—OPN4—glaucoma	0.00202	0.00573	CbGpPWpGaD
Pasireotide—SSTR1—Peptide ligand-binding receptors—C3—glaucoma	0.00202	0.00572	CbGpPWpGaD
Pasireotide—Vomiting—Methazolamide—glaucoma	0.00201	0.00311	CcSEcCtD
Pasireotide—Hypertension—Pilocarpine—glaucoma	0.00201	0.0031	CcSEcCtD
Pasireotide—SSTR1—GPCR downstream signaling—PTGFR—glaucoma	0.00201	0.00568	CbGpPWpGaD
Pasireotide—Gastrointestinal pain—Apraclonidine—glaucoma	0.002	0.00309	CcSEcCtD
Pasireotide—Abdominal pain upper—Timolol—glaucoma	0.002	0.00309	CcSEcCtD
Pasireotide—Nausea—Carbachol—glaucoma	0.00199	0.00308	CcSEcCtD
Pasireotide—Headache—Methazolamide—glaucoma	0.00198	0.00306	CcSEcCtD
Pasireotide—Myalgia—Pilocarpine—glaucoma	0.00198	0.00306	CcSEcCtD
Pasireotide—Arthralgia—Pilocarpine—glaucoma	0.00198	0.00306	CcSEcCtD
Pasireotide—SSTR5—GPCR downstream signaling—OPN4—glaucoma	0.00198	0.0056	CbGpPWpGaD
Pasireotide—Anxiety—Pilocarpine—glaucoma	0.00197	0.00305	CcSEcCtD
Pasireotide—Hypotension—Brimonidine—glaucoma	0.00196	0.00304	CcSEcCtD
Pasireotide—Nausea—Levobunolol—glaucoma	0.00196	0.00303	CcSEcCtD
Pasireotide—Nasopharyngitis—Timolol—glaucoma	0.00196	0.00303	CcSEcCtD
Pasireotide—Abdominal pain—Apraclonidine—glaucoma	0.00194	0.00299	CcSEcCtD
Pasireotide—Headache—Latanoprost—glaucoma	0.00192	0.00297	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Brimonidine—glaucoma	0.00192	0.00296	CcSEcCtD
Pasireotide—Decreased appetite—Acetazolamide—glaucoma	0.0019	0.00294	CcSEcCtD
Pasireotide—Insomnia—Brimonidine—glaucoma	0.0019	0.00294	CcSEcCtD
Pasireotide—SSTR3—Signaling by GPCR—PTGFR—glaucoma	0.0019	0.00538	CbGpPWpGaD
Pasireotide—SSTR2—Peptide ligand-binding receptors—EDN1—glaucoma	0.00189	0.00536	CbGpPWpGaD
Pasireotide—Fatigue—Acetazolamide—glaucoma	0.00189	0.00292	CcSEcCtD
Pasireotide—Alopecia—Clonidine—glaucoma	0.00188	0.00291	CcSEcCtD
Pasireotide—Nausea—Methazolamide—glaucoma	0.00188	0.0029	CcSEcCtD
Pasireotide—Hypotension—Dorzolamide—glaucoma	0.00188	0.0029	CcSEcCtD
Pasireotide—Hypotension—Travoprost—glaucoma	0.00187	0.00289	CcSEcCtD
Pasireotide—SSTR3—GPCR ligand binding—SMO—glaucoma	0.00187	0.00529	CbGpPWpGaD
Pasireotide—Hypotension—Brinzolamide—glaucoma	0.00184	0.00285	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Dorzolamide—glaucoma	0.00183	0.00283	CcSEcCtD
Pasireotide—SSTR2—GPCR downstream signaling—OPN4—glaucoma	0.00182	0.00517	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—PTGFR—glaucoma	0.00182	0.00516	CbGpPWpGaD
Pasireotide—Musculoskeletal discomfort—Travoprost—glaucoma	0.00182	0.00281	CcSEcCtD
Pasireotide—Insomnia—Dorzolamide—glaucoma	0.00182	0.00281	CcSEcCtD
Pasireotide—Fatigue—Brimonidine—glaucoma	0.00181	0.0028	CcSEcCtD
Pasireotide—SSTR3—Signaling Pathways—LRP12—glaucoma	0.0018	0.0051	CbGpPWpGaD
Pasireotide—Musculoskeletal discomfort—Brinzolamide—glaucoma	0.0018	0.00278	CcSEcCtD
Pasireotide—SSTR5—Signaling by GPCR—OPN4—glaucoma	0.00179	0.00509	CbGpPWpGaD
Pasireotide—SSTR5—Peptide ligand-binding receptors—C3—glaucoma	0.00179	0.00507	CbGpPWpGaD
Pasireotide—SSTR1—GPCR ligand binding—SMO—glaucoma	0.00179	0.00507	CbGpPWpGaD
Pasireotide—Insomnia—Brinzolamide—glaucoma	0.00179	0.00276	CcSEcCtD
Pasireotide—SSTR5—GPCR downstream signaling—PTGFR—glaucoma	0.00178	0.00504	CbGpPWpGaD
Pasireotide—SSTR3—G alpha (i) signalling events—C3—glaucoma	0.00178	0.00503	CbGpPWpGaD
Pasireotide—Hypotension—Pilocarpine—glaucoma	0.00177	0.00274	CcSEcCtD
Pasireotide—Asthenia—Apraclonidine—glaucoma	0.00176	0.00271	CcSEcCtD
Pasireotide—Decreased appetite—Dorzolamide—glaucoma	0.00175	0.0027	CcSEcCtD
Pasireotide—Pruritus—Apraclonidine—glaucoma	0.00173	0.00268	CcSEcCtD
Pasireotide—Fatigue—Dorzolamide—glaucoma	0.00173	0.00267	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Pilocarpine—glaucoma	0.00173	0.00267	CcSEcCtD
Pasireotide—SSTR1—Signaling Pathways—LRP12—glaucoma	0.00172	0.00489	CbGpPWpGaD
Pasireotide—Fatigue—Travoprost—glaucoma	0.00172	0.00266	CcSEcCtD
Pasireotide—Insomnia—Pilocarpine—glaucoma	0.00172	0.00265	CcSEcCtD
Pasireotide—Decreased appetite—Brinzolamide—glaucoma	0.00172	0.00265	CcSEcCtD
Pasireotide—Constipation—Travoprost—glaucoma	0.00171	0.00264	CcSEcCtD
Pasireotide—Hyperglycaemia—Timolol—glaucoma	0.00171	0.00264	CcSEcCtD
Pasireotide—Asthenia—Bimatoprost—glaucoma	0.0017	0.00263	CcSEcCtD
Pasireotide—SSTR1—G alpha (i) signalling events—C3—glaucoma	0.0017	0.00483	CbGpPWpGaD
Pasireotide—Fatigue—Brinzolamide—glaucoma	0.0017	0.00263	CcSEcCtD
Pasireotide—Pruritus—Bimatoprost—glaucoma	0.00168	0.0026	CcSEcCtD
Pasireotide—Diarrhoea—Apraclonidine—glaucoma	0.00168	0.00259	CcSEcCtD
Pasireotide—SSTR2—Signaling by GPCR—OPN4—glaucoma	0.00166	0.00469	CbGpPWpGaD
Pasireotide—SSTR2—Peptide ligand-binding receptors—C3—glaucoma	0.00165	0.00468	CbGpPWpGaD
Pasireotide—Decreased appetite—Pilocarpine—glaucoma	0.00165	0.00255	CcSEcCtD
Pasireotide—SSTR2—GPCR downstream signaling—PTGFR—glaucoma	0.00164	0.00465	CbGpPWpGaD
Pasireotide—Gastrointestinal pain—Dorzolamide—glaucoma	0.00164	0.00254	CcSEcCtD
Pasireotide—Alopecia—Betaxolol—glaucoma	0.00164	0.00253	CcSEcCtD
Pasireotide—Gastrointestinal pain—Travoprost—glaucoma	0.00163	0.00253	CcSEcCtD
Pasireotide—Constipation—Pilocarpine—glaucoma	0.00162	0.00251	CcSEcCtD
Pasireotide—Dizziness—Apraclonidine—glaucoma	0.00162	0.0025	CcSEcCtD
Pasireotide—SSTR3—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	0.00162	0.00458	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—PTGFR—glaucoma	0.00162	0.00458	CbGpPWpGaD
Pasireotide—SSTR5—GPCR ligand binding—SMO—glaucoma	0.00159	0.0045	CbGpPWpGaD
Pasireotide—Abdominal pain—Dorzolamide—glaucoma	0.00159	0.00245	CcSEcCtD
Pasireotide—Arthralgia—Clonidine—glaucoma	0.00158	0.00244	CcSEcCtD
Pasireotide—Abdominal pain—Travoprost—glaucoma	0.00158	0.00244	CcSEcCtD
Pasireotide—Anxiety—Clonidine—glaucoma	0.00157	0.00243	CcSEcCtD
Pasireotide—Asthenia—Acetazolamide—glaucoma	0.00157	0.00243	CcSEcCtD
Pasireotide—Dizziness—Bimatoprost—glaucoma	0.00157	0.00243	CcSEcCtD
Pasireotide—Vomiting—Apraclonidine—glaucoma	0.00156	0.00241	CcSEcCtD
Pasireotide—Gastrointestinal pain—Pilocarpine—glaucoma	0.00155	0.0024	CcSEcCtD
Pasireotide—SSTR1—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	0.00155	0.00439	CbGpPWpGaD
Pasireotide—Headache—Apraclonidine—glaucoma	0.00153	0.00237	CcSEcCtD
Pasireotide—SSTR5—Signaling Pathways—LRP12—glaucoma	0.00153	0.00433	CbGpPWpGaD
Pasireotide—SSTR5—G alpha (i) signalling events—C3—glaucoma	0.00151	0.00428	CbGpPWpGaD
Pasireotide—Asthenia—Brimonidine—glaucoma	0.00151	0.00233	CcSEcCtD
Pasireotide—Abdominal pain—Pilocarpine—glaucoma	0.0015	0.00232	CcSEcCtD
Pasireotide—Diarrhoea—Acetazolamide—glaucoma	0.0015	0.00232	CcSEcCtD
Pasireotide—Oedema peripheral—Timolol—glaucoma	0.00149	0.00231	CcSEcCtD
Pasireotide—Anaemia—Betaxolol—glaucoma	0.00149	0.00231	CcSEcCtD
Pasireotide—SSTR2—Signaling by GPCR—PTGFR—glaucoma	0.00149	0.00423	CbGpPWpGaD
Pasireotide—Pruritus—Brimonidine—glaucoma	0.00149	0.0023	CcSEcCtD
Pasireotide—Headache—Bimatoprost—glaucoma	0.00149	0.0023	CcSEcCtD
Pasireotide—SSTR2—GPCR ligand binding—SMO—glaucoma	0.00147	0.00415	CbGpPWpGaD
Pasireotide—Nausea—Apraclonidine—glaucoma	0.00145	0.00225	CcSEcCtD
Pasireotide—Vertigo—Betaxolol—glaucoma	0.00145	0.00224	CcSEcCtD
Pasireotide—Dizziness—Acetazolamide—glaucoma	0.00145	0.00224	CcSEcCtD
Pasireotide—Asthenia—Dorzolamide—glaucoma	0.00144	0.00223	CcSEcCtD
Pasireotide—Asthenia—Travoprost—glaucoma	0.00143	0.00222	CcSEcCtD
Pasireotide—Pruritus—Dorzolamide—glaucoma	0.00142	0.00219	CcSEcCtD
Pasireotide—Asthenia—Brinzolamide—glaucoma	0.00142	0.00219	CcSEcCtD
Pasireotide—Hypotension—Clonidine—glaucoma	0.00142	0.00219	CcSEcCtD
Pasireotide—Pruritus—Travoprost—glaucoma	0.00141	0.00219	CcSEcCtD
Pasireotide—SSTR3—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	0.00141	0.004	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—LRP12—glaucoma	0.00141	0.004	CbGpPWpGaD
Pasireotide—Nausea—Bimatoprost—glaucoma	0.00141	0.00218	CcSEcCtD
Pasireotide—Pruritus—Brinzolamide—glaucoma	0.0014	0.00216	CcSEcCtD
Pasireotide—SSTR2—G alpha (i) signalling events—C3—glaucoma	0.00139	0.00395	CbGpPWpGaD
Pasireotide—Vomiting—Acetazolamide—glaucoma	0.00139	0.00215	CcSEcCtD
Pasireotide—Dizziness—Brimonidine—glaucoma	0.00139	0.00215	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Clonidine—glaucoma	0.00138	0.00213	CcSEcCtD
Pasireotide—Myalgia—Betaxolol—glaucoma	0.00138	0.00213	CcSEcCtD
Pasireotide—Arthralgia—Betaxolol—glaucoma	0.00138	0.00213	CcSEcCtD
Pasireotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	0.00137	0.00389	CbGpPWpGaD
Pasireotide—Diarrhoea—Dorzolamide—glaucoma	0.00137	0.00212	CcSEcCtD
Pasireotide—Headache—Acetazolamide—glaucoma	0.00137	0.00212	CcSEcCtD
Pasireotide—Anxiety—Betaxolol—glaucoma	0.00137	0.00212	CcSEcCtD
Pasireotide—Insomnia—Clonidine—glaucoma	0.00137	0.00212	CcSEcCtD
Pasireotide—Diarrhoea—Travoprost—glaucoma	0.00137	0.00211	CcSEcCtD
Pasireotide—Asthenia—Pilocarpine—glaucoma	0.00136	0.0021	CcSEcCtD
Pasireotide—SSTR1—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	0.00135	0.00384	CbGpPWpGaD
Pasireotide—Diarrhoea—Brinzolamide—glaucoma	0.00135	0.00209	CcSEcCtD
Pasireotide—Pruritus—Pilocarpine—glaucoma	0.00134	0.00207	CcSEcCtD
Pasireotide—Alopecia—Timolol—glaucoma	0.00134	0.00207	CcSEcCtD
Pasireotide—Dizziness—Dorzolamide—glaucoma	0.00133	0.00205	CcSEcCtD
Pasireotide—Dizziness—Travoprost—glaucoma	0.00132	0.00204	CcSEcCtD
Pasireotide—Headache—Brimonidine—glaucoma	0.00132	0.00204	CcSEcCtD
Pasireotide—Decreased appetite—Clonidine—glaucoma	0.00132	0.00203	CcSEcCtD
Pasireotide—Fatigue—Clonidine—glaucoma	0.00131	0.00202	CcSEcCtD
Pasireotide—Dizziness—Brinzolamide—glaucoma	0.00131	0.00202	CcSEcCtD
Pasireotide—Nausea—Acetazolamide—glaucoma	0.0013	0.00201	CcSEcCtD
Pasireotide—Diarrhoea—Pilocarpine—glaucoma	0.0013	0.00201	CcSEcCtD
Pasireotide—Constipation—Clonidine—glaucoma	0.0013	0.002	CcSEcCtD
Pasireotide—Vomiting—Dorzolamide—glaucoma	0.00128	0.00197	CcSEcCtD
Pasireotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	0.00127	0.00359	CbGpPWpGaD
Pasireotide—Headache—Dorzolamide—glaucoma	0.00126	0.00194	CcSEcCtD
Pasireotide—Vomiting—Brinzolamide—glaucoma	0.00125	0.00194	CcSEcCtD
Pasireotide—Dizziness—Pilocarpine—glaucoma	0.00125	0.00194	CcSEcCtD
Pasireotide—Headache—Travoprost—glaucoma	0.00125	0.00194	CcSEcCtD
Pasireotide—Nausea—Brimonidine—glaucoma	0.00125	0.00193	CcSEcCtD
Pasireotide—SSTR3—Signaling Pathways—OPN4—glaucoma	0.00125	0.00353	CbGpPWpGaD
Pasireotide—Gastrointestinal pain—Clonidine—glaucoma	0.00124	0.00191	CcSEcCtD
Pasireotide—Headache—Brinzolamide—glaucoma	0.00124	0.00191	CcSEcCtD
Pasireotide—Hypotension—Betaxolol—glaucoma	0.00123	0.0019	CcSEcCtD
Pasireotide—SSTR3—GPCR ligand binding—EDN1—glaucoma	0.00123	0.00349	CbGpPWpGaD
Pasireotide—Vomiting—Pilocarpine—glaucoma	0.00121	0.00186	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Betaxolol—glaucoma	0.0012	0.00186	CcSEcCtD
Pasireotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	0.0012	0.0034	CbGpPWpGaD
Pasireotide—Abdominal pain—Clonidine—glaucoma	0.0012	0.00185	CcSEcCtD
Pasireotide—SSTR1—Signaling Pathways—OPN4—glaucoma	0.0012	0.00339	CbGpPWpGaD
Pasireotide—Insomnia—Betaxolol—glaucoma	0.00119	0.00184	CcSEcCtD
Pasireotide—Nausea—Dorzolamide—glaucoma	0.00119	0.00184	CcSEcCtD
Pasireotide—Headache—Pilocarpine—glaucoma	0.00119	0.00184	CcSEcCtD
Pasireotide—SSTR1—SIDS Susceptibility Pathways—VEGFA—glaucoma	0.00119	0.00337	CbGpPWpGaD
Pasireotide—Nausea—Travoprost—glaucoma	0.00119	0.00183	CcSEcCtD
Pasireotide—Vertigo—Timolol—glaucoma	0.00119	0.00183	CcSEcCtD
Pasireotide—SSTR1—GPCR ligand binding—EDN1—glaucoma	0.00118	0.00334	CbGpPWpGaD
Pasireotide—Nausea—Brinzolamide—glaucoma	0.00117	0.00181	CcSEcCtD
Pasireotide—SSTR3—Signaling Pathways—HEYL—glaucoma	0.00116	0.00328	CbGpPWpGaD
Pasireotide—Decreased appetite—Betaxolol—glaucoma	0.00115	0.00177	CcSEcCtD
Pasireotide—Hypertension—Timolol—glaucoma	0.00114	0.00176	CcSEcCtD
Pasireotide—Fatigue—Betaxolol—glaucoma	0.00114	0.00176	CcSEcCtD
Pasireotide—Constipation—Betaxolol—glaucoma	0.00113	0.00174	CcSEcCtD
Pasireotide—Nausea—Pilocarpine—glaucoma	0.00113	0.00174	CcSEcCtD
Pasireotide—Arthralgia—Timolol—glaucoma	0.00112	0.00174	CcSEcCtD
Pasireotide—Myalgia—Timolol—glaucoma	0.00112	0.00174	CcSEcCtD
Pasireotide—SSTR3—Signaling Pathways—PTGFR—glaucoma	0.00112	0.00318	CbGpPWpGaD
Pasireotide—Anxiety—Timolol—glaucoma	0.00112	0.00173	CcSEcCtD
Pasireotide—SSTR1—Signaling Pathways—HEYL—glaucoma	0.00111	0.00315	CbGpPWpGaD
Pasireotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	0.00111	0.00314	CbGpPWpGaD
Pasireotide—Asthenia—Clonidine—glaucoma	0.00109	0.00168	CcSEcCtD
Pasireotide—SSTR1—Signaling Pathways—PTGFR—glaucoma	0.00108	0.00305	CbGpPWpGaD
Pasireotide—SSTR3—GPCR ligand binding—C3—glaucoma	0.00108	0.00305	CbGpPWpGaD
Pasireotide—Pruritus—Clonidine—glaucoma	0.00107	0.00166	CcSEcCtD
Pasireotide—SSTR5—Signaling Pathways—OPN4—glaucoma	0.00106	0.003	CbGpPWpGaD
Pasireotide—SSTR5—GPCR ligand binding—EDN1—glaucoma	0.00105	0.00297	CbGpPWpGaD
Pasireotide—Diarrhoea—Clonidine—glaucoma	0.00104	0.0016	CcSEcCtD
Pasireotide—SSTR1—GPCR ligand binding—C3—glaucoma	0.00103	0.00292	CbGpPWpGaD
Pasireotide—SSTR1—SIDS Susceptibility Pathways—TNF—glaucoma	0.00102	0.00288	CbGpPWpGaD
Pasireotide—Hypotension—Timolol—glaucoma	0.00101	0.00156	CcSEcCtD
Pasireotide—Dizziness—Clonidine—glaucoma	0.001	0.00155	CcSEcCtD
Pasireotide—SSTR5—Signaling Pathways—HEYL—glaucoma	0.000986	0.00279	CbGpPWpGaD
Pasireotide—Musculoskeletal discomfort—Timolol—glaucoma	0.000982	0.00152	CcSEcCtD
Pasireotide—SSTR2—Signaling Pathways—OPN4—glaucoma	0.000978	0.00277	CbGpPWpGaD
Pasireotide—Insomnia—Timolol—glaucoma	0.000974	0.00151	CcSEcCtD
Pasireotide—SSTR2—SIDS Susceptibility Pathways—VEGFA—glaucoma	0.000972	0.00275	CbGpPWpGaD
Pasireotide—SSTR2—GPCR ligand binding—EDN1—glaucoma	0.000966	0.00274	CbGpPWpGaD
Pasireotide—Vomiting—Clonidine—glaucoma	0.000963	0.00149	CcSEcCtD
Pasireotide—SSTR3—Signaling by GPCR—SMO—glaucoma	0.000958	0.00272	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—PTGFR—glaucoma	0.000954	0.0027	CbGpPWpGaD
Pasireotide—Headache—Clonidine—glaucoma	0.000949	0.00147	CcSEcCtD
Pasireotide—Asthenia—Betaxolol—glaucoma	0.000946	0.00146	CcSEcCtD
Pasireotide—Decreased appetite—Timolol—glaucoma	0.000937	0.00145	CcSEcCtD
Pasireotide—Pruritus—Betaxolol—glaucoma	0.000933	0.00144	CcSEcCtD
Pasireotide—Fatigue—Timolol—glaucoma	0.000929	0.00144	CcSEcCtD
Pasireotide—SSTR1—Signaling by GPCR—SMO—glaucoma	0.000919	0.0026	CbGpPWpGaD
Pasireotide—SSTR5—GPCR ligand binding—C3—glaucoma	0.000914	0.00259	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—HEYL—glaucoma	0.00091	0.00258	CbGpPWpGaD
Pasireotide—Diarrhoea—Betaxolol—glaucoma	0.000902	0.00139	CcSEcCtD
Pasireotide—Nausea—Clonidine—glaucoma	0.0009	0.00139	CcSEcCtD
Pasireotide—Gastrointestinal pain—Timolol—glaucoma	0.000881	0.00136	CcSEcCtD
Pasireotide—SSTR2—Signaling Pathways—PTGFR—glaucoma	0.000881	0.0025	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—RPTOR—glaucoma	0.000878	0.00249	CbGpPWpGaD
Pasireotide—Dizziness—Betaxolol—glaucoma	0.000872	0.00135	CcSEcCtD
Pasireotide—Abdominal pain—Timolol—glaucoma	0.000852	0.00132	CcSEcCtD
Pasireotide—SSTR3—Signaling Pathways—NCK2—glaucoma	0.000851	0.00241	CbGpPWpGaD
Pasireotide—SSTR2—GPCR ligand binding—C3—glaucoma	0.000844	0.00239	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—RPTOR—glaucoma	0.000842	0.00239	CbGpPWpGaD
Pasireotide—Vomiting—Betaxolol—glaucoma	0.000839	0.0013	CcSEcCtD
Pasireotide—SSTR2—SIDS Susceptibility Pathways—TNF—glaucoma	0.000833	0.00236	CbGpPWpGaD
Pasireotide—Headache—Betaxolol—glaucoma	0.000826	0.00128	CcSEcCtD
Pasireotide—SSTR1—Signaling Pathways—NCK2—glaucoma	0.000816	0.00231	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—SMO—glaucoma	0.000815	0.00231	CbGpPWpGaD
Pasireotide—Nausea—Betaxolol—glaucoma	0.000783	0.00121	CcSEcCtD
Pasireotide—Asthenia—Timolol—glaucoma	0.000773	0.00119	CcSEcCtD
Pasireotide—Pruritus—Timolol—glaucoma	0.000762	0.00118	CcSEcCtD
Pasireotide—SSTR2—Signaling by GPCR—SMO—glaucoma	0.000752	0.00213	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—RPTOR—glaucoma	0.000747	0.00212	CbGpPWpGaD
Pasireotide—Diarrhoea—Timolol—glaucoma	0.000737	0.00114	CcSEcCtD
Pasireotide—SSTR3—Signaling Pathways—HDAC9—glaucoma	0.000723	0.00205	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—NCK2—glaucoma	0.000723	0.00205	CbGpPWpGaD
Pasireotide—Dizziness—Timolol—glaucoma	0.000712	0.0011	CcSEcCtD
Pasireotide—SSTR3—GPCR downstream signaling—EDN1—glaucoma	0.000696	0.00197	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—HDAC9—glaucoma	0.000693	0.00197	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—RPTOR—glaucoma	0.000689	0.00195	CbGpPWpGaD
Pasireotide—Vomiting—Timolol—glaucoma	0.000685	0.00106	CcSEcCtD
Pasireotide—Headache—Timolol—glaucoma	0.000675	0.00104	CcSEcCtD
Pasireotide—SSTR2—Signaling Pathways—NCK2—glaucoma	0.000668	0.00189	CbGpPWpGaD
Pasireotide—SSTR1—GPCR downstream signaling—EDN1—glaucoma	0.000667	0.00189	CbGpPWpGaD
Pasireotide—Nausea—Timolol—glaucoma	0.00064	0.000989	CcSEcCtD
Pasireotide—SSTR3—Signaling by GPCR—EDN1—glaucoma	0.000632	0.00179	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—HDAC9—glaucoma	0.000615	0.00174	CbGpPWpGaD
Pasireotide—SSTR3—GPCR downstream signaling—C3—glaucoma	0.000608	0.00172	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—EDN1—glaucoma	0.000606	0.00172	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—EDN1—glaucoma	0.000592	0.00168	CbGpPWpGaD
Pasireotide—SSTR1—GPCR downstream signaling—C3—glaucoma	0.000583	0.00165	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—HDAC9—glaucoma	0.000568	0.00161	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—SMO—glaucoma	0.000566	0.0016	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—C3—glaucoma	0.000552	0.00156	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—EDN1—glaucoma	0.000546	0.00155	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—SMO—glaucoma	0.000543	0.00154	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—EDN1—glaucoma	0.000537	0.00152	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—C3—glaucoma	0.000529	0.0015	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—NTRK2—glaucoma	0.000518	0.00147	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—C3—glaucoma	0.000517	0.00146	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—NTRK2—glaucoma	0.000496	0.00141	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—EDN1—glaucoma	0.000496	0.0014	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—SMO—glaucoma	0.000481	0.00136	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—C3—glaucoma	0.000477	0.00135	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—C3—glaucoma	0.000469	0.00133	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—NGFR—glaucoma	0.000444	0.00126	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—SMO—glaucoma	0.000444	0.00126	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—NTRK2—glaucoma	0.00044	0.00125	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—C3—glaucoma	0.000433	0.00123	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—NGFR—glaucoma	0.000426	0.00121	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—NTRK1—glaucoma	0.000422	0.0012	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—NTRK2—glaucoma	0.000406	0.00115	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—NTRK1—glaucoma	0.000405	0.00115	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—CDKN2B—glaucoma	0.000389	0.0011	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—NGFR—glaucoma	0.000378	0.00107	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—EDN1—glaucoma	0.000373	0.00106	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—CDKN2B—glaucoma	0.000373	0.00106	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—NTRK1—glaucoma	0.000359	0.00102	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—EDN1—glaucoma	0.000358	0.00101	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—NGFR—glaucoma	0.000349	0.000988	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—NGF—glaucoma	0.000343	0.000972	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—NTRK1—glaucoma	0.000331	0.000938	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—CDKN2B—glaucoma	0.000331	0.000937	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—NGF—glaucoma	0.000329	0.000932	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—C3—glaucoma	0.000326	0.000924	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—EDN1—glaucoma	0.000317	0.000899	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—C3—glaucoma	0.000313	0.000886	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—CDKN2B—glaucoma	0.000305	0.000865	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—APOE—glaucoma	0.000304	0.00086	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—CAV1—glaucoma	0.000301	0.000852	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—EDN1—glaucoma	0.000293	0.00083	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—NGF—glaucoma	0.000292	0.000826	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—APOE—glaucoma	0.000291	0.000825	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—CAV1—glaucoma	0.000288	0.000817	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—FN1—glaucoma	0.000286	0.000811	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—BAD—glaucoma	0.000283	0.000801	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—C3—glaucoma	0.000277	0.000785	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—FN1—glaucoma	0.000274	0.000778	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—BAD—glaucoma	0.000271	0.000768	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—NGF—glaucoma	0.000269	0.000763	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—APOE—glaucoma	0.000258	0.000731	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—C3—glaucoma	0.000256	0.000725	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—CAV1—glaucoma	0.000256	0.000725	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—FN1—glaucoma	0.000243	0.00069	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—BAD—glaucoma	0.00024	0.000681	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—APOE—glaucoma	0.000238	0.000675	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—CAV1—glaucoma	0.000236	0.000669	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—NOS3—glaucoma	0.000227	0.000644	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—FN1—glaucoma	0.000225	0.000636	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—BAD—glaucoma	0.000222	0.000629	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—NOS3—glaucoma	0.000218	0.000618	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—CDKN1B—glaucoma	0.000197	0.000558	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—NOS3—glaucoma	0.000193	0.000548	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—CDKN1B—glaucoma	0.000189	0.000535	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—MMP9—glaucoma	0.000182	0.000517	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—NOS3—glaucoma	0.000178	0.000506	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—MMP9—glaucoma	0.000175	0.000496	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—CDKN1B—glaucoma	0.000167	0.000475	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—VEGFA—glaucoma	0.000164	0.000464	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—VEGFA—glaucoma	0.000157	0.000445	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—MMP9—glaucoma	0.000155	0.00044	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—CDKN1B—glaucoma	0.000155	0.000438	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—MMP9—glaucoma	0.000143	0.000406	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—VEGFA—glaucoma	0.000139	0.000395	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—VEGFA—glaucoma	0.000129	0.000364	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—TP53—glaucoma	0.000124	0.000351	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—TP53—glaucoma	0.000119	0.000336	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—TP53—glaucoma	0.000105	0.000298	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—TP53—glaucoma	9.71e-05	0.000275	CbGpPWpGaD
